vs

Side-by-side financial comparison of Dexcom (DXCM) and INSPERITY, INC. (NSP). Click either name above to swap in a different company.

INSPERITY, INC. is the larger business by last-quarter revenue ($1.7B vs $1.3B, roughly 1.3× Dexcom). On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 3.4%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs -3.8%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

Insperity, Inc., previously known as Administaff, Inc., is a professional employer organization (PEO) headquartered in Kingwood, an area of Houston, Texas, USA. Insperity provides human resources and administrative services to small and medium-sized businesses. Since 2004, the company has been title sponsor of a professional golf tournament on the Champions Tour, previously known as the Administaff Small Business Classic.

DXCM vs NSP — Head-to-Head

Bigger by revenue
NSP
NSP
1.3× larger
NSP
$1.7B
$1.3B
DXCM
Growing faster (revenue YoY)
DXCM
DXCM
+18.2% gap
DXCM
21.6%
3.4%
NSP
Faster 2-yr revenue CAGR
DXCM
DXCM
Annualised
DXCM
12.0%
-3.8%
NSP

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DXCM
DXCM
NSP
NSP
Revenue
$1.3B
$1.7B
Net Profit
$267.3M
Gross Margin
62.9%
10.3%
Operating Margin
25.6%
-2.8%
Net Margin
21.2%
Revenue YoY
21.6%
3.4%
Net Profit YoY
153.6%
EPS (diluted)
$0.67
$-0.87

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
NSP
NSP
Q1 26
$1.3B
Q4 25
$1.3B
$1.7B
Q3 25
$1.2B
$1.6B
Q2 25
$1.2B
$1.7B
Q1 25
$1.0B
$1.9B
Q4 24
$1.1B
$1.6B
Q3 24
$994.2M
$1.6B
Q2 24
$1.0B
$1.6B
Net Profit
DXCM
DXCM
NSP
NSP
Q1 26
$267.3M
Q4 25
$267.3M
Q3 25
$283.8M
$-20.0M
Q2 25
$179.8M
$-5.0M
Q1 25
$105.4M
$51.0M
Q4 24
$151.7M
Q3 24
$134.6M
$3.0M
Q2 24
$143.5M
$18.0M
Gross Margin
DXCM
DXCM
NSP
NSP
Q1 26
62.9%
Q4 25
62.9%
10.3%
Q3 25
60.5%
12.0%
Q2 25
59.5%
13.4%
Q1 25
56.9%
16.6%
Q4 24
58.9%
13.5%
Q3 24
59.7%
14.7%
Q2 24
62.4%
16.2%
Operating Margin
DXCM
DXCM
NSP
NSP
Q1 26
25.6%
Q4 25
25.6%
-2.8%
Q3 25
20.1%
-1.5%
Q2 25
18.4%
-0.4%
Q1 25
12.9%
3.7%
Q4 24
17.0%
-0.9%
Q3 24
15.3%
0.1%
Q2 24
15.7%
1.4%
Net Margin
DXCM
DXCM
NSP
NSP
Q1 26
21.2%
Q4 25
21.2%
Q3 25
23.5%
-1.2%
Q2 25
15.5%
-0.3%
Q1 25
10.2%
2.7%
Q4 24
13.6%
Q3 24
13.5%
0.2%
Q2 24
14.3%
1.1%
EPS (diluted)
DXCM
DXCM
NSP
NSP
Q1 26
$0.67
Q4 25
$0.67
$-0.87
Q3 25
$0.70
$-0.53
Q2 25
$0.45
$-0.14
Q1 25
$0.27
$1.35
Q4 24
$0.37
$-0.21
Q3 24
$0.34
$0.07
Q2 24
$0.35
$0.48

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
NSP
NSP
Cash + ST InvestmentsLiquidity on hand
$917.7M
$682.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.7B
$46.0M
Total Assets
$6.3B
$2.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
NSP
NSP
Q1 26
$917.7M
Q4 25
$917.7M
$682.0M
Q3 25
$1.8B
$521.0M
Q2 25
$1.2B
$511.0M
Q1 25
$904.9M
$684.0M
Q4 24
$606.1M
$1.2B
Q3 24
$621.2M
$596.0M
Q2 24
$939.2M
$850.0M
Stockholders' Equity
DXCM
DXCM
NSP
NSP
Q1 26
$2.7B
Q4 25
$2.7B
$46.0M
Q3 25
$2.7B
$87.0M
Q2 25
$2.6B
$112.0M
Q1 25
$2.3B
$119.0M
Q4 24
$2.1B
$97.0M
Q3 24
$2.0B
$125.0M
Q2 24
$2.4B
$142.0M
Total Assets
DXCM
DXCM
NSP
NSP
Q1 26
$6.3B
Q4 25
$6.3B
$2.2B
Q3 25
$7.5B
$2.0B
Q2 25
$7.3B
$2.0B
Q1 25
$6.8B
$2.1B
Q4 24
$6.5B
$2.6B
Q3 24
$6.4B
$1.9B
Q2 24
$6.8B
$2.1B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DXCM
DXCM
NSP
NSP
Operating Cash FlowLast quarter
$255.0M
Free Cash FlowOCF − Capex
$246.0M
FCF MarginFCF / Revenue
14.7%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-309.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DXCM
DXCM
NSP
NSP
Q1 26
Q4 25
$294.0M
$255.0M
Q3 25
$659.9M
$-11.0M
Q2 25
$303.0M
$-79.0M
Q1 25
$183.8M
$-443.0M
Q4 24
$301.4M
$619.0M
Q3 24
$199.5M
$-150.0M
Q2 24
$279.4M
$20.0M
Free Cash Flow
DXCM
DXCM
NSP
NSP
Q1 26
Q4 25
$192.1M
$246.0M
Q3 25
$579.4M
$-20.0M
Q2 25
$208.9M
$-86.0M
Q1 25
$96.8M
$-449.0M
Q4 24
$176.8M
$606.0M
Q3 24
$88.3M
$-164.0M
Q2 24
$213.3M
$14.0M
FCF Margin
DXCM
DXCM
NSP
NSP
Q1 26
Q4 25
15.3%
14.7%
Q3 25
47.9%
-1.2%
Q2 25
18.1%
-5.2%
Q1 25
9.3%
-24.1%
Q4 24
15.9%
37.6%
Q3 24
8.9%
-10.5%
Q2 24
21.2%
0.9%
Capex Intensity
DXCM
DXCM
NSP
NSP
Q1 26
Q4 25
8.1%
0.5%
Q3 25
6.7%
0.6%
Q2 25
8.1%
0.4%
Q1 25
8.4%
0.3%
Q4 24
11.2%
0.8%
Q3 24
11.2%
0.9%
Q2 24
6.6%
0.4%
Cash Conversion
DXCM
DXCM
NSP
NSP
Q1 26
Q4 25
1.10×
Q3 25
2.33×
Q2 25
1.69×
Q1 25
1.74×
-8.69×
Q4 24
1.99×
Q3 24
1.48×
-50.00×
Q2 24
1.95×
1.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DXCM
DXCM

Segment breakdown not available.

NSP
NSP

Northeast$455.0M27%
West$339.0M20%
Southwest$317.0M19%
Central$299.0M18%
Southeast$241.0M14%
Other Revenues$17.0M1%

Related Comparisons